We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advan... Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing. Show more
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into securities purchase agreements with certain...
Announces early access availability of ProteoVue Software ProteoVue is part of broader set of innovation initiatives, including the Company’s recently announced collaboration with NVIDIA, to...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors...
Expands Distribution Network to Accelerate Global Adoption of Platinum® Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announced...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has introduced the Platinum Library Prep Kit, V2, an advanced tool for...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced the launch of its protein Barcoding Kit designed to transform protein...
Provides Update on the Company’s Innovation Roadmap & New Development Partnerships Highlights new Distribution Agreement with Avantor in the U.S. and Canada Quantum-Si Incorporated (Nasdaq:...
Agreement Expands Access to Pioneering Proteomics Technology Across the U.S. and Canadian Markets Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein...
Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the...
Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.445 | 12.7142857143 | 3.5 | 5.77 | 2.47 | 104987661 | 3.93766123 | CS |
4 | 2.515 | 175.874125874 | 1.43 | 5.77 | 1.1703 | 57244846 | 3.11295474 | CS |
12 | 3.1204 | 378.413776376 | 0.8246 | 5.77 | 0.6121 | 25717733 | 2.5713737 | CS |
26 | 3 | 317.46031746 | 0.945 | 5.77 | 0.6121 | 12025322 | 2.53404759 | CS |
52 | 2.055 | 108.73015873 | 1.89 | 5.77 | 0.6121 | 6484433 | 2.47859874 | CS |
156 | -2.965 | -42.9088277858 | 6.91 | 6.9698 | 0.6121 | 2798684 | 2.5634244 | CS |
260 | -6.805 | -63.3023255814 | 10.75 | 14.17 | 0.6121 | 2524589 | 3.01646698 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions